ZNF227 Activators
ZNF227 employ various intracellular signaling pathways to modulate the function of this protein. Forskolin, through its ability to directly activate adenylyl cyclase, results in an increased concentration of cAMP within the cell. This boost in cAMP levels leads to the activation of protein kinase A (PKA), which in turn can phosphorylate ZNF227, thereby enhancing its DNA-binding activity and its role in the regulation of gene transcription. Similarly, Rolipram, by inhibiting phosphodiesterase 4 (PDE4), prevents the breakdown of cAMP, thereby sustaining elevated levels of this messenger molecule, which consequently promotes PKA activation and subsequent phosphorylation of ZNF227. Other agents that elevate cAMP levels, such as Epinephrine, Isoproterenol, PGE2, and Glucagon, also stimulate adenylyl cyclase activity via their interaction with specific cell surface receptors, leading to the activation of PKA and subsequent phosphorylation of ZNF227.
Ionomycin increases intracellular calcium concentrations, which can activate calmodulin-dependent kinases, potentially resulting in the phosphorylation of ZNF227. Bay K8644, as a calcium channel agonist, similarly elevates calcium levels and might likewise lead to the activation of kinases that phosphorylate ZNF227. IBMX increases the intracellular levels of cAMP and cGMP by inhibiting phosphodiesterases, which leads to PKA activation and could enhance the phosphorylation state of ZNF227. Anisomycin, though primarily a protein synthesis inhibitor, activates stress-activated protein kinases, such as JNK, which then may phosphorylate ZNF227. Parathyroid hormone (1-34) and its receptor interaction, as well as the use of a cAMP analog like 8-Br-cAMP, are additional means by which the activation of PKA and subsequent phosphorylation of ZNF227 can be achieved, thereby modulating its activity in gene regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4 (PDE4), which prevents the breakdown of cAMP. This results in increased cAMP levels, which, similar to Forskolin, could activate PKA. The activated PKA could then phosphorylate ZNF227, leading to an increase in its transcription regulatory activity. | ||||||
Parathyroid hormone fragment (1-34) | 52232-67-4 | sc-487943 | 100 µg | $185.00 | ||
Parathyroid hormone (1-34) binds to its receptor, PTHR1, leading to the activation of the cAMP/PKA signaling pathway. The downstream cascade may include the phosphorylation of transcription factors, such as ZNF227, thereby increasing its activity in gene regulation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate calmodulin-dependent kinase (CaMK), which potentially phosphorylates transcription factors like ZNF227, leading to its functional activation. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with adrenergic receptors, which can lead to the activation of cAMP/PKA signaling pathways. Activation of PKA could lead to phosphorylation and activation of ZNF227, which enhances its function as a transcription factor. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, stimulates the production of cAMP, thereby activating PKA. PKA activation may result in the phosphorylation and subsequent activation of ZNF227, promoting its transcription regulatory functions. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 binds to its G protein-coupled receptors (GPCRs), leading to increased cAMP production. This elevation in cAMP may activate PKA, which can then phosphorylate and activate ZNF227, enhancing its activity as a transcription factor. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Bromoadenosine 3',5'-cyclic monophosphate (8-Br-cAMP) is a cell-permeable cAMP analog that can activate PKA. Activated PKA could phosphorylate ZNF227, thus potentially leading to its activation and increased transcriptional activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, leading to increased cAMP and cGMP levels. The increased cAMP may result in PKA activation, which could phosphorylate ZNF227, leading to its functional activation as a transcription factor. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Bay K8644 is a calcium channel agonist that increases intracellular calcium concentrations. Elevated calcium levels can activate CaMK, which may phosphorylate and activate ZNF227, increasing its transcriptional activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases (SAPKs), such as JNK. Activated JNK has been shown to phosphorylate transcription factors, which could include ZNF227, leading to its functional activation in gene regulatory processes. | ||||||